CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Clinical trials for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) explained in plain language.
Never miss a new study
Get alerted when new CHRONIC LYMPHOCYTIC LEUKEMIA (CLL) trials appear
Sign up with your email to follow new studies for CHRONIC LYMPHOCYTIC LEUKEMIA (CLL), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for blood cancer patients when first treatment stops working
Disease control Not yet recruitingThis study is testing whether a combination of two targeted drugs (acalabrutinib and venetoclax) can effectively treat patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL) when their cancer returns after successful first-line treatment. The trial w…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: PHASE2 • Sponsor: AstraZeneca • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
Scientists hunt genetic clues to predict leukemia treatment success
Knowledge-focused Not yet recruitingThis study aims to understand how specific genetic characteristics in patients with chronic lymphocytic leukemia (CLL) influence their response to treatment. Researchers will observe 45 newly diagnosed adult patients, collecting detailed medical history, physical exam data, and l…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Sponsor: Assiut University • Aim: Knowledge-focused
Last updated Apr 04, 2026 05:06 UTC
-
Scientists probe how exercise fights cancer from within
Knowledge-focused Not yet recruitingThis study aims to understand why strength training improves the health of people with various cancers. Researchers will enroll 150 patients with lung, breast, colon, blood, or lymph node cancers. Half will do supervised strength training twice a week for 12 weeks, while the othe…
Matched conditions: CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
Phase: NA • Sponsor: University of Salamanca • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:38 UTC